Conditioned Medium of Soybean Extract Treated Osteoblasts Inhibits RANKL Induced Differentiation of Osteoclasts
![]() ![]() |
Park, Kyung-Ho
(Dept. of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University)
Ju, Won-Chul (Dept. of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University) Yeo, Joo-Hong (Dept. of Agricultural Biology, National Academy of Agricultural Science) Lee, Kwang-Gill (Dept. of Agricultural Biology, National Academy of Agricultural Science) Cho, Yun-Hi (Dept. of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University) |
1 | Kim J, Um SJ, Woo J, Kim JY, Kim HA, Jang KH, Kang SA, Lim BO, Kang I, Choue RW, Cho Y. 2005. Comparative effect of seeds of Rhynchosia volubilis and soybean on MG-63 human osteoblastic cell proliferation and estrogenicity. Life Sci 78: 30-40. DOI |
2 | Kameda T, Mano H, Yuasa T, Mori Y, Miyazawa K, Shiokawa M, Nakamaru Y, Hiroi E, Hiura K, Kameda A, Yang NN, Hakeda Y, Kumegawa M. 1997. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone resorbing osteoclasts. J Exp Med 186: 489-495. DOI |
3 | Mok SK, Shin LLS. 1996. The effects of prostaglandine and dibutylryl cAMP on osteoblastic cell activity and osteoclast generation. J Wonkwang Dental Res Int 6: 43-62. |
4 | Anderson JJB, Garner SC. 1998. Phytoestrogens and bone. Baillieres Best Tract Res Clin Endocrinol Metab 12: 543-557. DOI |
5 | Setchell KDR, Cassidy A. 1999. Dietary isoflavones: Biological effects and relevance to human health. J Nutr 129: 758-767. DOI |
6 | Um SJ, Kang IS, Cho Y. 2005. Study on role of estrogen receptor-alpha in yak-kong and soybean induced proliferation of MG-63 human osteoblastic cells. Korean J Nutrition 34: 905-911. |
7 | Sugimoto E, Yamaguchi M. 2000. Anabolic effect of genistein in osteoblastic MC3T3-E1 cells. Int J Mol Med 5: 515-520. |
8 | Milsicek RJ. 1994. Interaction of naturally occurring nonsteroidal estrogen with expressed recombinant human estrogen receptor. J Steroid Biochem Mol Biol 49: 153-160. DOI |
9 |
Kurolouchi K, Kambe F, Yasukawa K, Izumi R, Ishiguro N, Iwata H. 1998. TNF- |
10 | Jilka RL. 1998. Cytokines, bone remodeling, and estrogen deficiency: a 1998 update. Bone 23: 75-81. DOI |
11 | Lorenz CH, Armin EH. 1997. Osteoprotegerin: a novel local player in bone metabolism. Eur J Endocrinol 137: 345-346. DOI |
12 | Rogers J. 1967. Estrogens in the menopause and postmenopause. N Engl J Med 280: 364-367. |
13 | Baker VL, Leitman D, Jaffe RB. 2000. Selective estrogen receptor modulators in reproductive medicine and biology. Obstet Gynecol Surv 55: 21-47. DOI ScienceOn |
14 | Aldercreutz H, Mazur W. 1996. Phyto-oestrogens in relation to cancer and other human health risks. Proc Nutr Soc 55: 399-417. DOI ScienceOn |
15 | Khosla S. 2001. Minireview: the OPG/RANKL/RANK system. Endocrinology 142: 5050-5055. DOI |
16 | Chambers TJ. 2000. Regulation of the differentiation and function of osteoclasts. J Pathol 192: 4-13. DOI |
17 | Sanae K, Seishiro H, Fujio K. 2004. Effects of the phytoestrogen coumesterol on RANK-ligand-induced differentiation of osteoclasts. Toxicology 203: 211-220. DOI |
18 | Thomas C, Spelsberg M, Subramaniam B, Lawrence R, Sundeep K. 2005. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endo 13: 819-828. DOI |
19 | Gowen M, Wood D, Ihrie EJ, McGuire KB, Russell RG. 1983. An interleukin 1 like factor stimulates bone resorption in vitro. Nature 306: 378-380. DOI |
20 | Hotokejaka H, Sakai E, Kanaoka K, Saito K, Matsuo KI, Kitaura H, Yoshida N, Nakayama K. 2002. U0126 and PD98059, specific inhibition of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. J Biol Chem 277: 47366-47372. DOI |
21 | Kang SA, Jang KH, Cho YH, Hong KH, Kong SH, Choue RW. 2001. High performance liquid chromatographic analysis of isoflavones in soybean and blackbean. J Arahe 8:44-48. |
22 | Kameda T, Mano H, Yuasa T, Mori Y, Miyazawa K, Shiokawa M, Nakamaru Y, Hiroi E, Hiura K, Kameda A, Yang NN, Hakeda Y, Kumegawa M. 1997. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med 186: 489-495. DOI |
23 | Luo XH, Liao EY. 2003. Effects of estriol on the proliferation and differentiation of human osteoblastic MG-63 cells. Endocr Res 29: 343-351. DOI ScienceOn |
24 | Srivastava S, Toraldo G, Weitzmann MN, Cenci S, Ross FP, Pacifici R. 2001. Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation. J Biol Chem 276: 8836-8840. DOI |
25 | Parfitt AM. 1994. Osteonal and hemi-osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem 55: 273-286. DOI |
26 | Udagawa N, Takakashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T. 1990. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA 87: 7260-7264. DOI |
27 |
Kong YY, Boyle WJ, Penninger JM. 2001. Osteoprotegerin and receptor activator of nuclear factor |
28 | Arnett TR. 1990. Update on bone cell biology. Eur J Orthod 12: 81-90. DOI |
![]() |